1. Introduction
There are 429 national park sites, including battlefields and monuments, in the United States. The total land area covers more than 84 million acres in the United States (50 states, the District of Columbia) and US territories (American Samoa, Guam, Puerto Rico, and the Virgin Islands) [
1]. Sixty-three of these sites are titled “national parks” in the United States and U.S. territories and comprise the main park locations within the national park system. These 63 parks within the continental US and Hawaii (designated as the US National Parks by the National Park Service) are the focus of this report, as they account for the largest land areas of public use and are known for outdoor recreation, tent camping, and backpacking. Additionally, the National Park Service officially designates these 63 areas as U.S. national parks. The overall number of visitors to the national park system totaled more than 325 million in 2023 [
2], while the 63 national parks welcome about 92 million visitors annually. This brief report considers 61 designated national parks due to data availability, and given the sizable acreage coverage the parks consume in the U.S., along with the high number of visitors.
Ectoparasite, and particularly tick presence in national parks, are not currently established. Medically important disease-causing ectoparasites are generally categorized as arthropods or arachnids. Within the arthropod category, mosquitoes are the most predominant vectors of human disease; ticks are second. The true number of human tick-borne disease cases is largely unknown, particularly outside of areas considered non-endemic, as states maintain different reporting practices, and local vs. travel-acquired disease is not generally reported at the county level. Additionally, data across years are not readily available for diseases other than Lyme. Analyzing risk is typically established through tick testing, but those data are sparse. For national parks outside of the Northeast, human disease reports are limited, and, similar to other counties across the U.S., reports often fail to note the geographic location where the tick bite encounter occurred.
This observational report aims to stimulate discourse regarding the patchwork collection of limited official data to which researchers have access, identifying national parks as an example of multiple tick-borne disease data limitations. Importantly, a host of data limitations currently prevent researchers from properly establishing disease risk. These include (1) official tick-borne disease data are scattered by year and disease; (2) lack of locally vs. travel-acquired disease data makes quality research difficult, as official disease reports fail to confirm disease acquisition within a park location or at the county level; (3) national parks are difficult to study, as official disease data exist primarily at state levels, which are often reported for brief time periods.
Identifying knowledge gaps is an essential component of zoonotic disease prevention [
3]. Tick-borne disease risk has been evaluated in individual parks and regions (e.g., the Northeast). These studies typically focus on specific geographic areas within a given park(s), on a particular tick species, or on human or wildlife reports of disease [
4,
5,
6,
7,
8,
9]. A comprehensive study of tick-borne disease (TBD) risk in U.S. national parks concluded that a lack of systematic surveillance for vector-borne pathogens equates to unknown risk for employees and visitors [
5]. This 2013 study also notes the limits of TBD data secured from neighboring communities rather than the actual parks, given varying terrains and human behavior differences [
5]. I, therefore, consider outdoor activities in the national parks, such as camping and hiking, and report human, canine, and tick data only in counties that overlap with park boundaries in this observational report.
With limited disease surveillance, visitors who become infected in a national park may fail to link a park visit to subsequent flu-like illness, arthritis, anxiety, or a host of other TBD symptoms [
10,
11]. The CDC notes that Lyme arthritis, for example, can develop within one to a few months post-infection [
10]. Pace and O’Reilly, in Journal: Tickborne Diseases: Diagnosis and Management, state that “Tickborne diseases are increasing in incidence and should be suspected in patients presenting with flulike symptoms during the spring and summer months. Prompt diagnosis and treatment can prevent complications and death. Location of exposure, identification of the specific tick vector, and evaluation of rash, if present, help identify the specific disease” [
12]. Tick bites are typically small and may go unnoticed; however, symptoms with the absence of a tick bite history do not exclude a TBD [
13]. Those infected with tick-borne diseases may not develop symptoms for weeks and may test negative if they started antibiotics or are tested within the first few weeks before antibodies have developed [
14,
15]. It typically takes 4–6 weeks for Lyme disease tests, in particular, to appear positive [
14,
15].
Camping and hiking off trails are both risk factors in tick and tick-borne disease exposure [
16]. Although travel history and details of summer activities are necessary for diagnosis, medical interviews typically neglect these discussions [
13]. There is also evidence that exposure via occupation, for example, may increase TBD risk. Park rangers were found to be at increased risk of Lyme disease [
17]. Additionally, park employees from Rocky Mountain and Great Smoky Mountains National Parks were found to be infected with spotted fever group
rickettsiae and
B. henselae at both sites and other TBDs in Great Smoky Mountains National Parks [
4].
The objective of this Brief Report is not to assess risk or provide a formal methodology, but rather to document known and unknown variables, recognize data limitations, and stimulate future research that includes more nuanced data, such as tick presence and tick testing, particularly within national parks, forests, or grasslands outside of the Northeast, where dogs are allowed, and in parks where canine serological reports of confirmed disease do not align with human disease cases. I conclude that nuanced studies are warranted across all national park areas in the U.S., particularly in areas suspected to be non-endemic, and where emerging tick-borne diseases are not yet established.
2. Tick-Borne Disease Data and National Parks
This brief report depicts TBD presence in 61 out of the 63 national parks in the United States due to data availability. Each park’s geographical coordinates were correlated to a county through LatLong.net using the main park entrance address as provided by the National Park Service. Counties serve as approximate locations for the parks, as some parks span multiple counties. Following Eisen et al. (2013) recommendations, disease data that align with park location were collected rather than data from surrounding communities where employees or visitors may not be present and where behaviors, such as camping or hiking, may also be less likely [
5].
The informal methodology is an observational approach to document confirmed cases of disease, using county-level data that overlaps with national park locations. I evaluate human and canine confirmed cases in parks that allow tent camping and where dogs are welcome.
Ixodes scapularis tick presence reported and established, is presented for 13 of the counties as tick testing is limited. Canine-human disease alignment is also examined. Numerous studies have been undertaken using one or more of the same factors; these studies illuminate biological and ecological nuances; for example, the discovery of a specific tick species above 7000 feet and within sagebrush or noting national park employees’ increased risk of exposure or disease [
3,
4,
5,
6,
7].
Data were selected by availability. The Centers for Disease Control and Prevention offer TBD data at the county level for diseases other than Lyme Disease only from 2016 to 2019. Given that these are the only official county-level TBD data currently available to researchers across states, the CDC data set was selected. Each TBD case report during the selected CDC-reported years is provided in table format.
Tables and maps are utilized to demonstrate the presence of TBDs at any point in time, indicating human or canine TBD presence is established.
The review includes tables and maps that detail the following:
Total visitors to national parks, including numbers for tent camping and backpacking. Data on national park visitation and usage were obtained from the U.S. National Park Service and cited in
Appendix A.
Incidences of human TBDs by proxy county for each national park geographic area.
Canine cases with confirmed TBD serology in each national park geographic area.
Ixodes scapularis tick presence, 2024 CDC.
Thematic and overlaid mapping of select TBDs with U.S. national parks.
Methodological notes: Many emerging tick-borne diseases are not mandated as reportable diseases to states and consequently are excluded from this report. Discrepancies in years among tables occur due to varying data accessibility. The maps were generated using Excel (Microsoft 365) and the DataWrapper App (2024), an online mapping tool. The overlay maps present a visual representation of established TBDs and do not establish actual risk.
3. Observations
There is evidence that TBDs are reported in most of the United States National Park areas in this report, either via canine serology or human testing within the county. Exceptions include Great Basin National Park (Nevada), Great Sand Dunes National Park and Preserve (Colorado), Guadalupe Mountains (Texas), and the two national parks in Hawaii. These parks either had zero or very low case reports. However, in some cases (e.g., Hawaii), human reports are zero, while canine TBD case reports are present.
Acadia (Maine) and Voyageurs National Park (Minnesota) geographic areas had the highest human Lyme disease incidences and high overall canine TBDs. The top national park locations for canine Lyme disease were Shenandoah, Acadia, New River Gorge National Park and Preserve, Isle Royale, and Voyageurs.
Tables and maps are presented below, documenting national park visitation, human tick-borne disease reports in national park geographic areas, canine TBDs by national park-county location, and
Ixodes scapularis tick presence in counties where data are available. Additional information is located in
Appendix A,
Appendix B and
Appendix C.
3.1. U.S. National Park Visitation
The top 15 most visited parks are provided in
Table 1. This table also includes the number of tent campers and backpackers in 2022.
Appendix A provides a full table of national parks included in this study with historical visitation and camper visits.
3.2. Human Tick-Borne Diseases in U.S. National Parks
Table 2 presents human TBD data from the CDC from varying years, as available [
18,
19].
Table 2 includes diseases transmitted by both hard and soft tick vectors. Argasid (soft ticks) transmit all relapsing fever
borreliae (except
B recurrentis) [
20]. The American Dog Tick and Rocky Mountain Wood Tick (soft ticks) are vectors for spotted fever, and the American Dog Tick can also spread Tularemia. Both are included in the human case data below.
National parks shaded in green are those with the highest number of visitors and secondary criteria as the highest number of those with tent campers in 2022. The top three parks with the highest number of visitors, tent campers, and TBDs were Acadia, Hot Springs, and Indiana Dunes. The top 15 parks for overall human TBD reports include (from largest to smallest) Acadia; Voyageurs; Hot Springs; Indiana Dunes; Biscayne; Redwood; Cuyahoga Valley; Congaree; Gateway Arch; Joshua Tree; Shenandoah; Isle Royale; Channel Islands; Mount Rainier; and Everglades.
Additional observational analyses of TBD reports at the most visited US National Parks are also provided, first for the largest total number of human tick-borne diseases reported in the county and next by the largest number of visitors.
Table 2 indicates that Voyageurs National Park geographic area (Minnesota) has close to the same number of total human TBDs as the Acadia National Park area (Maine) and more than parks found in Ohio and Virginia. Other observations include elevated levels of reported TBDs over a short period in some of the most visited national parks.
3.3. Canine Tick-Borne Diseases in U.S. National Parks
Using a One Health approach, noting the connectivity of human diseases to that of animals and the shared environment, canine TBD reports were included. Canine anaplasmosis was notably high in Acadia, indeed, almost 2 ½ times higher than canine LD. Shenandoah National Park geographic area (Virginia) has the highest number of canine LD cases, with Acadia, New River Gorge National Park and Preserve (West Virginia), and Voyageurs (Minnesota) geographic locations with notably high cases of LD, respectively. Importantly, canine data indicate that LD is not always the most prevalent and, in some cases, absent, even in the presence of high TBDs, such as anaplasmosis (Capital Reef, Utah) or ehrlichiosis (Mammoth Cave, Kentucky).
Table 3 shows national park areas by order of highest canine TBDs. Orange-highlighted rows indicate national parks where dogs are allowed within the park. Six out of the eleven parks allowing dogs had total TBDs over 10%. The average total tick-borne diseases combined (i.e., Lyme disease, ehrlichiosis, and anaplasmosis) for parks allowing dogs is 15.34%, while the average for parks without dogs is 8.7%. National park geographic areas that permit canine companions have a higher average total tick-borne disease reports in the respective county. By individual diseases, average positive serology reports for canines in parks allowing dogs were LD-4.5%, erhlichiosis-5.6%, and anaplasmois-5.3%. Where dogs are not allowed: LD-1.7%, erhlichiosis-3.4%, and anaplasmosis-3.7%. In sum, across all diseases, parks that allow canine companions demonstrate higher reports of TBDs in canines. The majority of national parks allowing dogs tend to be geographically located in the east-south-central and west-south-central regions, including states such as Arkansas or Kentucky, with known tick expansion. However, two national parks in Arizona are unique, as one (Petrified Forest) allows dogs and has high TBD rates. In contrast, the second (Grand Canyon) does not allow canines and has considerably lower reports of canine TBDs. Both areas have similar topography, but the Petrified Forest ecology is shortgrass prairie and some grasslands with diverse plants and animals [
21].
Table 4 provides the highest percent of positive tests among canines in counties that represent national parks in the U.S. national park locations shaded in orange represent overlap with the highest human TBD cases. Human TBD cases include diseases, such as Rocky Mountain spotted fever, that canines may acquire but for which data are not available. Observationally, overlap between human and canine confirmed cases occurs in eastern portions of the U.S. In some cases, western regions of the U.S. report over 25% positive canine serology but considerably smaller reports of any human TBD.
Table 5 provides Blacklegged Tick (
Ixodes scapularis) presence data, either reported or established in 13 of the national park geographic regions. Data were not collected or available for all other proxy counties. Established tick presence is defined as “Six or more
I. scapularis … of a single life stage, or more than one life stage of the tick collected in the county within a 12-month period” [
22]. Reported ticks are defined as ”Less than six
I. scapularis …of a single life stage collected in the county within a 12-month period” [
22]. Counties classified as “no records” do not imply tick absence. No records may result from no sampling efforts in the county, tick collection, or reporting.
Ixodes scapularis is found primarily across the eastern United States, including the Northeast, mid-Atlantic, and parts of the Midwest. I. scapularis vectors transmit the following pathogens: Borrelia burgdorferi and B. mayonii (both cause Lyme disease); B. miyamotoi disease (one type of relapsing fever); Ehrlichia muris eauclairensis (ehrlichiosis); Anaplasma phagocytophilum (anaplasmosis); Babesia microti (babesiosis); Powassan virus (Powassan virus disease); and tick paralysis. Tick paralysis is more commonly transmitted, however, by the Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick).
Dermacentor variabilis and
Dermacentor andersoni are also associated with spotted fever diseases. Spotted fevers develop via the bacteria
Rickettsia. Rocky Mountain spotted fever is the most common of the spotted fevers in the U.S. and is known to overlap geographically with other TBDs.
Table 5 shows geographic areas where both diseases are reported in humans.
3.4. Thematic Tick-Borne Disease Mapping
Thematic maps in this brief report are not intended to represent the biological and ecological interactions needed to assess actual TBD risk in U.S. national parks. Thematic choropleth maps simply present a visual representation of established TBD presence.
Figure 1 presents an overlay representation of RMSP on national park locations.
Figure 2 offers a visual representation of human and canine TBD cases using data over available years. The maps indicate that TBDs are present across all 61 observed U.S. national parks. Additional maps of all human TBDs between 2016 and 2019 are provided in
Appendix B.
4. Key Observations and Recommendations
This brief report asks readers to consider the complexity of diagnosis and public health communication with asymmetric or insufficient tick-borne disease data. Further analyses are recommended that include multimodal data approaches using canine, tick-presence, wildlife, ecosystem, human activities (e.g., tent camping or backpacking), and other factors that contribute to local understanding of disease risk, particularly in widely visited outdoor recreation areas, such as the national parks. Comparative data may enhance further research. Observationally, for example, canine and human data reports of TBDs are not aligned and warrant further study.
Given the tables and maps presented in this report, the following observations and recommendations are presented to assist with future TBD research in national parks:
Tick-borne diseases are established across almost all U.S. national park geographic areas, including Alaska, the southern tip of Florida, the Midwest, and the Western United States. However, in many instances, only one report of an individual disease between 2016 and 2019 is documented. It is not established that these case reports were locally acquired. The lack of locally acquired human data at the county level generally results in researchers pulling data from canines, tick presence, and other ecological or geographic variables to provide improved risk assessments. Recommendation: States should require reporting that includes locally acquired vs. travel-acquired patient history. Researchers may wish to access tick presence data from commercial tick collection laboratories to fill in data gaps.
The most prevalent canine diseases for all national park areas were ehrlichiosis, anaplasmosis, and LD, respectively. For humans, the largest number of cases were LD, spotted fever, Rickettsia, anaplasmosis, ehrlichiosis, babesiosis, and tularemia, respectively. Canine testing panels might include multiple TBDs, while human testing may focus on ruling out LD specifically. Recommendation: further research should consider the lack of alignment between canine and human disease reports.
Acadia National Park geographic area, as represented by Hancock County, has the highest number of human LD and highest rates of canine anaplasmosis, also indicating a potential lapse in comparable testing.
Outside of Maine’s Acadia NP, the Mammoth Cave National Park area (Kentucky) has the second highest rate of canine TBD, particularly ehrlichiosis.
Importantly, canine data are useful in demonstrating that LD is not always the most prevalent and, in some cases, absent, even in the presence of high TBDs, such as anaplasmosis (Capital Reef NP, Utah) or ehrlichiosis (Mammoth Cave NP, Kentucky). After Mammoth Cave, Hot Springs and Yellowstone National Park geographic areas have the highest number of canine ehrlichiosis cases across all national parks.
The county overlapping Hot Springs National Park in Arkansas accounts for almost 2/3 of all human cases of Rocky Mountain spotted fever in all the national park geographic areas, with Congaree (South Carolina) and Gateway Arches National Park (Utah) second and third, respectively. Hot Springs (Arkansas) also has the largest number of human ehrlichiosis cases. Recommendation: the Centers for Disease Control and Prevention should expand access to all years for all TBDs at the county-level to better inform public health in assessing TBD trends.
Voyageurs National Park in Minnesota warrants the attention of public health officials. With over 1300 LD cases in three years, in addition to 56 cases of anaplasmosis, Voyageurs overall appears as likely a place to contract TBDs as Maine’s Acadia National Park. Further research is needed that incorporates additional data and, preferably, more years. Note: The Lyme Disease Association, Inc. awarded a grant to create county-level data guidebooks for all U.S. counties. This work will be completed in 2025 and will be open access [
25].
Available disease data vary over the years, so useful comparisons using multimodal data sets require improved data availability by states and the CDC. County-level data for all TBDs, if made available, would greatly enhance disease risk knowledge. Disease risk assessment is also improved by considering the abundance of infected ticks in addition to human behavior known to increase the likelihood of a tick bite encounter [
26]. Recommendation: combining numerous data sets that cover human and pet activity, in addition to geological and ecological variables across all parks has the potential to improve collective public health knowledge.
Although it appears that allowing canine companions in national parks is potentially associated with increased positive canine serology reports, many of the parks allowing dogs are found in states with known TBB risk, e.g., Kentucky and Arkansas. However, only one state, Maine, has a national park that allows dogs in the Northeastern U.S. A nuanced review of ecological factors, tick presence, and additional One Health variables to review this observation is needed.
Comparing individual TBDs provides additional areas for further study. Using the raw data and maps of individual human TBDs in national park geographic areas (
Appendix A,
Appendix B and
Appendix C) shows that TBDs are concentrated in different parks. The highest concentration outliers typically occur in only one or two parks. Lyme Disease (Maine and Minnesota); Babesiosis (Maine and Minnesota); Ehrlichiosis (Arkansas); Anaplasmosis (Maine and Minnesota); spotted fever (Arkansas); and Tularemia (Colorado). Using the highest case reports may indicate more locally acquired, as there are more data points, and can potentially serve as useful data for medical practitioners assessing potential patient co-infections in a region where a tick bite encounter or travel occurred.
Recommendation: The CDC and states should offer county-level data for all TBDs, including emerging TBDs, for extended periods. State-level data are not helpful to public health officials outside of the Northeast, as many larger states have varied ecosystems representing different levels of risk. New data collection efforts are currently in progress to collect county-level data on all TBDs through grant-funded research [
27].
Recommendation: Future research should concentrate on the changing geographic distributions and ecologies of ticks within the parks. For example, forest fragments with fewer predators and animal life promote areas with more white-footed mice, and hence the potential for increased TBD risk. Nuanced studies are indicated, as, for example, mice are known to prefer forested habitats and, in one study, were not likely to leave their habitat for neighboring private yards [
28]. Given that geographical and ecological differences exist within park boundaries, capturing specific tick species and animal biodiversity indicators with advanced methodologies that include multiple indicators can enhance risk assessment in U.S. national parks.
Recommendation: National parks are encouraged to conduct tick awareness campaigns, educating visitors about the risk of ticks. The National Park Service could also conduct tick collection and testing programs, sampling ticks and asking visitors to report tick bite encounters within park boundaries.